A Cloud-Based Artificial Intelligence Framework for Risk Assessment in Post-Transplant Patient Management
Main Article Content
Abstract
The COVID-19 pandemic exposed serious weaknesses in the delivery of routine healthcare services, particularly for patients who depend on continuous medical supervision, such as kidney transplant recipients. During periods of lockdown and restricted movement, many patients were unable to visit hospitals for regular follow-ups, laboratory tests, or specialist consultations. This situation was especially challenging in public healthcare institutions, where limited medical staff must serve a very large patient population. As a result, many transplant patients were left without timely medical advice, increasing the risk of undetected complications and treatment delays.
Even in the years following the pandemic, several of these challenges have not been fully resolved. Public hospitals continue to face heavy patient loads, access to specialists remains limited, and regular in-person monitoring is still difficult for many patients. The gap between urban and rural healthcare services further complicates long-term disease management, making remote and technology-supported care an important requirement rather than a convenience. For transplant recipients, who need lifelong monitoring and strict medication adherence, the lack of consistent follow-up can have serious consequences for graft survival and overall health.
To respond to these persistent challenges, this paper presents a cloud-based, artificial intelligence–enabled framework for risk assessment and decision support in post-transplant patient management. The proposed system integrates cloud computing infrastructure, machine learning models, and a clinical knowledge base to analyze patient-reported symptoms and health data. Based on this analysis, the platform classifies patient risk levels and provides appropriate guidance, such as follow-up recommendations or medication-related advice. A simple and accessible web interface allows patients to receive clinical support without the need for frequent hospital visits, thereby reducing both travel burden and exposure to crowded healthcare environments.
To evaluate the practical usefulness of the system, a user survey was conducted with 100 kidney transplant recipients. The majority of participants reported that the platform was easy to use, helpful for routine health monitoring, and suitable for long-term adoption. Users particularly valued the ability to receive timely guidance and reassurance without waiting for in-person appointments. The findings suggest that such an AI-driven cloud platform can play an important role in improving continuity of care, enhancing patient engagement, and supporting early identification of potential health issues.
Overall, this study demonstrates that intelligent, cloud-based healthcare systems can address ongoing gaps in post-transplant care delivery. By combining remote accessibility with automated risk assessment, the proposed framework offers a practical solution for strengthening patient support in both post-pandemic and resource-constrained healthcare settings.